6-K ·Filed Jul 9, 2026

GSK

GSK plc
NEUTRAL
Impact 1/10
Horizonimmediate Processed2mo ago SEC0001654954-26-006560
Notable filing: 6-K
Actionable Insight • Neutral

This is a routine PDMR plan acquisition of 8.955 notional ADS worth ~$478. No material trading signal. Monitor next quarterly earnings for fundamental updates on GSK's pipeline and revenue trajectory.

DirectionNeutral
Confidencehigh
Horizonimmediate
Latest settled — T+20d ⚠ clustered
GSK ▼ -0.57% at T+20d
NEUTRAL call ✗ call lost -0.57% · α vs SPY -2.81% · entry $52.47 → $52.17
Next anchor: T+60d due 8h ago
Latest observation: T+58 +1.68% FF3 residual α
Entry anchored
Jul 9, 11:27 AM ET
via exchange tick
T+1d
+0.59%
call +0.59% · α +0.16%
$52.78
settled 3mo ago
T+5d
+0.57%
call +0.57% · α +0.70%
$52.77
settled 3mo ago
T+20d
-0.57%
call -0.57% · α -2.81%
$52.17
settled 8w ago
T+60d
—
call — · α —
—
due 8h ago

Price Chart

Loading chart...

Executive Summary

GSK filed a Form 6-K reporting a routine PDMR transaction: Maya Martinez-Davis, President US, acquired 8.955 notional ADS at $53.32 within her Executive Supplemental Savings Plan account. This is a standard compensation-related plan acquisition with no material financial impact.

Key Facts

  • Maya Martinez-Davis, President US, acquired 8.955 notional ADS at $53.32 on July 7, 2026
  • Acquisition was within the GSK Executive Supplemental Savings Plan account
  • Transaction value approximately $477.50
  • Filing is a routine PDMR transaction notification under UK market abuse regulation

Financial Impact

Transaction value approximately $477.50 — immaterial relative to GSK's $106.4B market cap

Risk Factors

  • No material risk identified from this filing

Market Snapshot

Exchange
OTC
Sector
Pharmaceutical Preparations
Analyst Consensus
43% bullish (30 analysts)

Investment Themes

Biotech & Drug Discovery

Documents Analyzed

This report is based on 4 SEC documents filed with EDGAR.

DocumentAccession Number
6-K Filing (Primary)0001654954-26-006560
Document: 0001654954-26-006560-index-headers.html0001654954-26-006560
Document: 0001654954-26-006560-index.html0001654954-26-006560
Document: 0001654954-26-006560.txt0001654954-26-006560
42 reports for GSK
Performance horizon
69% Hit rate 11 of 16 directional calls best @ T+60▲ +7.85%Jun 16, 2026
Filters
Rows
Reports for GSK — sortable, filterable
TypeNow
Sep 15, 2026
17d ago
6-K
NEUTRAL ★ 5/10
$50.01 $50.22▲ +0.42%▼ −0.40%$47.03 (−5.96%)
Sep 14, 2026
18d ago
6-K
BULLISH ★ 7/10
$50.05 $51.08▲ +2.06%▲ +1.95%$47.03 (−6.03%)
Sep 14, 2026
18d ago
6-K
BULLISH ★ 7/10
$50.05 $51.08▲ +2.06%▲ +1.95%$47.03 (−6.03%)
Sep 11, 2026
21d ago
6-K
NEUTRAL ★ 1/10
$48.13 $50.22▲ +4.34%▲ +4.56%$47.03 (−2.29%)
Sep 10, 2026
22d ago
6-K
NEUTRAL ★ 1/10
$48.12 $51.06▲ +6.11%▲ +6.61%$47.03 (−2.27%)
Sep 10, 2026
22d ago
6-K
NEUTRAL ★ 3/10
$48.12 $51.06▲ +6.11%▲ +6.61%$47.03 (−2.27%)
Sep 1, 2026
4w ago
6-K
NEUTRAL ★ 1/10
$50.66 $48.63▼ −4.01%▼ −4.09%$47.03 (−7.17%)
Sep 1, 2026
4w ago
6-K
BULLISH ★ 6/10
$50.66 $48.63▼ −4.01%▼ −4.09%$47.03 (−7.17%)
Aug 26, 2026
5w ago
6-K
NEUTRAL ★ 1/10
$51.43 $50.44▼ −1.92%▼ −1.80%$47.03 (−8.56%)
Aug 24, 2026
5w ago
6-K
NEUTRAL ★ 2/10
$51.78 $50.25▼ −2.95%▼ −3.42%$47.03 (−9.17%)
Showing 10 of 42

US Market Status

Market Closed — Opens Mon (65h 4m)

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access